BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $622,000 | -13.5% | 8,020 | -4.2% | 0.09% | -1.1% |
| Q4 2021 | $719,000 | -37.2% | 8,371 | -41.1% | 0.09% | 0.0% |
| Q3 2021 | $1,144,000 | +0.3% | 14,220 | +0.3% | 0.09% | 0.0% |
| Q2 2021 | $1,141,000 | -22.1% | 14,172 | -18.4% | 0.09% | -14.4% |
| Q1 2021 | $1,465,000 | -3.4% | 17,371 | -8.1% | 0.10% | -1.0% |
| Q4 2020 | $1,516,000 | +13.8% | 18,898 | +14.1% | 0.10% | -8.7% |
| Q3 2020 | $1,332,000 | +29.8% | 16,567 | +39.0% | 0.12% | -12.9% |
| Q2 2020 | $1,026,000 | +10.7% | 11,915 | +4.3% | 0.13% | -22.8% |
| Q1 2020 | $927,000 | +55.0% | 11,421 | +59.8% | 0.17% | +59.8% |
| Q4 2019 | $598,000 | -7.9% | 7,148 | -3.6% | 0.11% | -12.3% |
| Q3 2019 | $649,000 | +5.7% | 7,414 | -1.1% | 0.12% | +6.1% |
| Q2 2019 | $614,000 | -1.0% | 7,499 | -1.7% | 0.12% | -5.7% |
| Q1 2019 | $620,000 | +24.2% | 7,625 | +0.6% | 0.12% | +7.0% |
| Q4 2018 | $499,000 | -21.0% | 7,577 | -7.5% | 0.11% | -21.4% |
| Q3 2018 | $632,000 | -11.0% | 8,193 | -14.7% | 0.14% | -2.0% |
| Q2 2018 | $710,000 | -0.7% | 9,610 | -12.6% | 0.15% | +12.1% |
| Q1 2018 | $715,000 | -19.5% | 10,997 | -12.1% | 0.13% | -12.0% |
| Q4 2017 | $888,000 | +2.4% | 12,515 | -0.2% | 0.15% | -5.7% |
| Q3 2017 | $867,000 | +4.7% | 12,545 | +2.5% | 0.16% | +3.2% |
| Q2 2017 | $828,000 | +115.6% | 12,241 | +120.3% | 0.15% | +41.3% |
| Q1 2017 | $384,000 | -82.4% | 5,556 | -88.1% | 0.11% | +18.5% |
| Q4 2016 | $2,176,000 | -2.7% | 46,736 | -0.5% | 0.09% | -18.6% |
| Q3 2016 | $2,236,000 | -26.6% | 46,967 | -28.2% | 0.11% | +2.7% |
| Q2 2016 | $3,047,000 | +2.1% | 65,402 | -7.6% | 0.11% | -1.8% |
| Q1 2016 | $2,985,000 | -42.1% | 70,752 | -47.7% | 0.11% | +13.1% |
| Q4 2015 | $5,157,000 | +22.2% | 135,180 | +7.9% | 0.10% | +10.0% |
| Q3 2015 | $4,220,000 | -54.5% | 125,264 | -5.5% | 0.09% | -49.2% |
| Q2 2015 | $9,270,000 | +1.3% | 132,555 | -0.8% | 0.18% | +2.9% |
| Q1 2015 | $9,154,000 | -6.7% | 133,632 | -0.1% | 0.17% | -7.0% |
| Q4 2014 | $9,808,000 | +1.6% | 133,827 | -0.5% | 0.18% | -4.1% |
| Q3 2014 | $9,656,000 | -3.0% | 134,452 | -2.9% | 0.19% | +1.0% |
| Q2 2014 | $9,953,000 | -3.0% | 138,470 | -1.0% | 0.19% | -6.4% |
| Q1 2014 | $10,265,000 | -31.9% | 139,808 | -35.5% | 0.20% | +3.6% |
| Q4 2013 | $15,072,000 | -15.4% | 216,730 | -15.7% | 0.20% | -10.5% |
| Q2 2013 | $17,813,000 | – | 257,154 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |